Proteomics for the Development of DNA Tolerizing Vaccines to Treat Autoimmune Disease
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 103 (1) , 7-12
- https://doi.org/10.1006/clim.2002.5185
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K08 AR02133, 5R01NS18235, K08 AI01521, U19 DK61934)
- Donald E. and Delia B. Baxter Foundation (K08 AR02133, 5R01NS18235, K08 AI01521, U19 DK61934)
- Arthritis Foundation (K08 AR02133, 5R01NS18235, K08 AI01521, U19 DK61934)
- National Institute of Neurological Disorders and Stroke (K08 AR02133, 5R01NS18235, K08 AI01521, U19 DK61934)
This publication has 45 references indexed in Scilit:
- β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trialThe Lancet, 2001
- Liquid Flows in MicrochannelsPublished by Taylor & Francis ,2001
- Combination of Gene Delivery and DNA Vaccination to Protect from and Reverse Th1 Autoimmune Disease via Deviation to the Th2 PathwayImmunity, 2001
- Vaccination with Glutamic Acid Decarboxylase Plasmid DNA Protects Mice from Spontaneous Autoimmune Diabetes and B7/CD28 Costimulation Circumvents That ProtectionClinical Immunology, 2001
- Major peptide autoepitopes for nucleosome-specific T cells of human lupusJournal of Clinical Investigation, 1999
- Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic proteinNature, 1996
- The Underestimated Long Term Medical and Economic Consequences of Rheumatoid ArthritisDrugs, 1995
- Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of AutoantigensAnnual Review of Immunology, 1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic miceNature, 1993